Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.
暂无分享,去创建一个
Denis Lacombe | Wolfgang Grisold | M. J. van den Bent | M. Taphoorn | A. Brandes | T. Gorlia | A. Allgeier | D. Lacombe | M. Sanson | J. Kros | C. Vecht | C. Tijssen | A. Carpentier | Martin J van den Bent | Marc Sanson | Thierry Gorlia | W. Grisold | Marc Frenay | Charles J Vecht | M. Frénay | Martin J B Taphoorn | Antoine F Carpentier | Alba A Brandes | Hans J J A Bernsen | Cees C Tijssen | Laslo Sipos | Hanny Haaxma-Reiche | Johannes M Kros | Mathilde C M van Kouwenhoven | Anouk Allgeier | H. Bernsen | H. Haaxma-Reiche | L. Sipos
[1] P. Loehrer. Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma , 2006 .
[2] W R Markesbery,et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. , 1998, JAMA.
[3] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[4] A. Twijnstra,et al. Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy , 1998, Neurology.
[5] G S Bauman,et al. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. , 2000, International journal of radiation oncology, biology, physics.
[6] A. Algra,et al. Oligoastrocytomas: a clinicopathological study of 52 cases , 1997, Journal of Neuro-Oncology.
[7] T. Cascino,et al. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Richard J. Kryscio,et al. Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain , 1998 .
[9] L. Stewart,et al. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials , 2002, The Lancet.
[10] A. Verma. MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma , 2006 .
[11] B. Scheithauer,et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] T. Cascino,et al. Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] M. Piérart,et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial , 2005, The Lancet.
[14] B. Scheithauer,et al. An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus radiation (RT) versus RT alone for pure and mixed anaplastic oligodendrogliomas: Initial report of RTOG 94-02. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Diethelm Wallwiener,et al. Authors' Disclosures of Potential Conflicts of Interest The authors indicated no potential conflicts of interest. , 2004 .
[16] D K Pearl,et al. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas , 1997, Cancer.
[17] M. J. van den Bent,et al. Recent developments in the molecular characterization and treatment of oligodendroglial tumors. , 2003, Neuro-oncology.
[18] E. Alexander,et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. , 1978, Journal of neurosurgery.
[19] D. Louis,et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.
[20] M. J. van den Bent,et al. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features , 2003, Cancer.